Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Marco Massari and Nicola Facciolongo.
Marco Massari
Connection Strength
0.694
Nicola Facciolongo
  1. Tocilizumab in Treatment for Patients With COVID-19-Reply. JAMA Intern Med. 2021 07 01; 181(7):1019-1020.
    View in: PubMed
    Score: 0.238
  2. Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation. Crit Care. 2020 09 29; 24(1):589.
    View in: PubMed
    Score: 0.226
  3. Human Dental Pulp Stem Cells Modulate Cytokine Production in vitro by Peripheral Blood Mononuclear Cells From Coronavirus Disease 2019 Patients. Front Cell Dev Biol. 2020; 8:609204.
    View in: PubMed
    Score: 0.058
  4. Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial. JAMA Intern Med. 2021 01 01; 181(1):24-31.
    View in: PubMed
    Score: 0.058
  5. Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia. Clin Exp Rheumatol. 2020 Nov-Dec; 38(6):1215-1222.
    View in: PubMed
    Score: 0.057
  6. TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol. Contemp Clin Trials. 2020 11; 98:106165.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.